Plus Therapeutics | 8-K: Current report
Mar 14 17:07 ET
Plus Therapeutics | 8-K: Current report
Mar 13 08:03 ET
Plus Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Mar 8 16:32 ET
Plus Therapeutics | 8-K: Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Mar 5 16:13 ET
Plus Therapeutics | 10-K: Annual report
Mar 5 16:03 ET
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard
Feb 26 18:32 ET
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaFrance Norman D.
Feb 26 18:32 ET
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HEDRICK MARC H
Feb 26 18:27 ET
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sims Andrew John Hugh MacIntyre
Feb 26 18:27 ET
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P
Feb 26 18:27 ET
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director van Es-Johansson An
Feb 26 18:27 ET
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hawkins Richard J
Feb 26 18:27 ET
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Petersen Greg
Feb 26 18:26 ET
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer HEDRICK MARC H
Dec 15, 2023 17:09 ET
Plus Therapeutics | 424B3: Prospectus
Nov 22, 2023 16:22 ET
Plus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Nov 22, 2023 16:08 ET
Plus Therapeutics | EFFECT: Others
Nov 21, 2023 00:15 ET
Plus Therapeutics | 8-K: Current report
Nov 20, 2023 07:01 ET
Plus Therapeutics | CORRESP: CORRESP
Nov 17, 2023 13:49 ET
Plus Therapeutics | UPLOAD: Others
Nov 17, 2023 11:36 ET
No Data
No Data